Related references
Note: Only part of the references are listed.Depiction of tumor stemlike features and underlying relationships with hazard immune infiltrations based on large prostate cancer cohorts
Chuanjie Zhang et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Immune response drives outcomes in prostate cancer: implications for immunotherapy
Jialin Meng et al.
MOLECULAR ONCOLOGY (2021)
Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer
Ying Z. Mazzu et al.
MOLECULAR ONCOLOGY (2020)
Construction and Validation of a Robust Cancer Stem Cell-Associated Gene Set-Based Signature to Predict Early Biochemical Recurrence in Prostate Cancer
Bide Liu et al.
DISEASE MARKERS (2020)
Targeting AR-Beclin 1 complex-modulated growth factor signaling increases the antiandrogen Enzalutamide sensitivity to better suppress the castration-resistant prostate cancer growth
Meng Zhang et al.
CANCER LETTERS (2019)
A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)
Ying Z. Mazzu et al.
CLINICAL CANCER RESEARCH (2019)
Key Genes And Pathways Controlled By E2F1 In Human Castration-Resistant Prostate Cancer Cells
Qingniao Zhou et al.
ONCOTARGETS AND THERAPY (2019)
N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway
Yu Yin et al.
MOLECULAR CANCER (2019)
Achieving PSA < 0.2 ng/ml before Radiation Therapy Is a Strong Predictor of Treatment Success in Patients with High-Risk Locally Advanced Prostate Cancer
Akira Kazama et al.
PROSTATE CANCER (2019)
Management of Biochemical Recurrence after Primary Curative Treatment for Prostate Cancer: A Review
Walter Artibani et al.
UROLOGIA INTERNATIONALIS (2018)
CDKN3 expression is an independent prognostic factor and associated with advanced tumor stage in nasopharyngeal carcinoma
Shih-Lun Chang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2018)
Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer
Lingjian Yang et al.
EBIOMEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators
Lei Wei et al.
EUROPEAN UROLOGY (2017)
Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset
Woonyoung Choi et al.
EUROPEAN UROLOGY (2017)
Long-term Outcome of Prostate Cancer Patients Who Exhibit Biochemical Failure Despite Salvage Radiation Therapy After Radical Prostatectomy
James Ying et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2017)
Cyclin-dependent kinase inhibitor 3 (CDKN3) plays a critical role in prostate cancer via regulating cell cycle and DNA replication signaling
Chao Yu et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
DEPDC1 promotes cell proliferation and tumor growth via activation of E2F signaling in prostate cancer
Lin Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Translating RNA sequencing into clinical diagnostics: opportunities and challenges
Sara A. Byron et al.
NATURE REVIEWS GENETICS (2016)
Clinical significance of RacGAP1 expression at the invasive front of gastric cancer
Susumu Saigusa et al.
GASTRIC CANCER (2015)
Antitumor mechanisms when pRb and p53 are genetically inactivated
L. Zhu et al.
ONCOGENE (2015)
HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle network
Antonio Ramos-Montoya et al.
EMBO MOLECULAR MEDICINE (2014)
The prognostic value of ribonucleotide reductase small subunit M2 in predicting recurrence for prostate cancers
Yasheng Huang et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Analysis of genetic aberrations on chromosomal region 8q21-24 identifies E2F5 as an oncogene with copy number gain in prostate cancer
Jin Zhao et al.
MEDICAL ONCOLOGY (2013)
Identification of early molecular markers for breast cancer
Celine Kretschmer et al.
MOLECULAR CANCER (2011)
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
Jack Cuzick et al.
LANCET ONCOLOGY (2011)
Impact of Biochemical Recurrence in Prostate Cancer Among US Veterans
Edward M. Uchio et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Cell-Context Specific Role of the E2F/Rb Pathway in Development and Disease
Victoria A. Swiss et al.
GLIA (2010)
Regularization Paths for Generalized Linear Models via Coordinate Descent
Jerome Friedman et al.
JOURNAL OF STATISTICAL SOFTWARE (2010)
The E2F family and the role of E2F1 in apoptosis
Zhenlong Wu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
E2Fs mediate a fundamental cell-cycle deregulation in high-grade serous ovarian carcinomas
T. De Meyer et al.
JOURNAL OF PATHOLOGY (2009)
Emerging roles of E2Fs in cancer: an exit from cell cycle control
Hui-Zi Chen et al.
NATURE REVIEWS CANCER (2009)
Broad overexpression of ribonucleotide reductase genes in mice specifically induces lung neoplasms
Xia Xu et al.
CANCER RESEARCH (2008)
E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non-small-cell lung cancer
Cheng-long Huang et al.
CLINICAL CANCER RESEARCH (2007)
Involvement of E2F transcription factor family in cancer
PK Tsantoulis et al.
EUROPEAN JOURNAL OF CANCER (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
MgcRacGAP controls the assembly of the contractile ring and the initiation of cytokinesis
WM Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Survival model predictive accuracy and ROC curves
PJ Heagerty et al.
BIOMETRICS (2005)
Long-term outcomes after radical prostatectomy performed in a community-based health maintenance organization
Y Zhang et al.
CANCER (2004)
Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: Genome-wide gene-expression profiles of prostate cancers and PINs
S Ashida et al.
CANCER RESEARCH (2004)
MgcRacGAP is involved in cytokinesis through associating with mitotic spindle and midbody
K Hirose et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
